What does Prolia (denosumab) cost if you pay cash?
Prolia pricing varies a lot by pharmacy, dose, and whether you buy through a manufacturer program or a specialty pharmacy. With no insurance, the cash price is often substantially higher than insured rates.
How much is a typical “without insurance” Prolia dose?
Prolia is given as a 60 mg injection once every 6 months. The out-of-pocket cash cost is commonly priced per dose (per injection), so your total depends on whether you’re quoted per 6-month supply. If you can share your country (and whether you need one dose or multiple), I can help narrow down what shoppers usually see.
Does the Prolia manufacturer offer a copay card or assistance?
Manufacturer “copay card” programs generally require commercial insurance and do not help most people who are uninsured. Some countries also have patient assistance programs for eligible patients without coverage, but eligibility depends on income and other factors.
Can you lower the cost by switching pharmacies or using specialty delivery?
Yes. Prolia is frequently dispensed by specialty pharmacies, and cash prices can differ across:
- Your local pharmacy vs. a specialty pharmacy
- Different retail chains
- Mail-order specialty pharmacies (if available)
Calling for a cash price for the next scheduled shipment is often the fastest way to find the best rate.
What should you ask the pharmacy to get an accurate cash quote?
When requesting a quote without insurance, ask:
- The price for one 60 mg dose (not just “a vial”)
- Whether delivery fees or administration fees are included
- Whether they apply any discount program or manufacturer program
- The expected start date so the dosing schedule is consistent (every 6 months)
Are there cheaper alternatives to Prolia that don’t require insurance?
There may be other osteoporosis treatments, but whether they’re cheaper depends on the medication and your specific medical situation. If you tell me what you’re using Prolia for (osteoporosis vs. other indications) and whether you’ve had fractures, I can help compare general options you can discuss with your clinician.
Source
- DrugPatentWatch.com (for related product/patent context): https://www.drugpatentwatch.com